|1.||Chien, Wenwen: 1 article (04/2015)|
|2.||Poellinger, Lorenz: 1 article (04/2015)|
|3.||Wuensche, Peer: 1 article (04/2015)|
|4.||Yang, Henry: 1 article (04/2015)|
|5.||Koeffler, H Phillip: 1 article (04/2015)|
|6.||Mori, Seiichi: 1 article (04/2015)|
|7.||Tyner, Jeffrey W: 1 article (04/2015)|
|8.||Lee, Kian Leong: 1 article (04/2015)|
|9.||Tokatly, Itay: 1 article (04/2015)|
|10.||Torres-Fernandez, Lucia A: 1 article (04/2015)|
01/01/2014 - "In vivo penfluridol was particularly effective at inhibiting LL/2 lung tumor growth, and obviously prolonged the survival time of mice bearing LL/2 lung tumors implanted subcutaneously. "
01/01/2014 - "To test this, we conducted a study to determine whether penfluridol exerts cytotoxic effects on tumor cells and, if so, to explore its anti-tumor mechanisms. "
01/01/2014 - "Our results suggested that penfluridol is not only cytotoxic to cancer cells in vitro but can also inhibit tumor growth in vivo. "
01/01/2014 - "Animal tumor models of these cancer cells were established and to evaluate penfluridol for its anti-tumor efficacy in vivo. "
01/01/2014 - "Growth inhibition of mouse cancer cell lines by penfluridol was determined using the 3- (4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. "
|2.||Tourette Syndrome (Tourette's Syndrome)
|3.||Schizophrenia (Dementia Praecox)
08/01/1978 - "A controlled study of penfluridol in the treatment of chronic schizophrenia."
04/01/1977 - "During the first part of a long-term study, penfluridol received a high degree of patient acceptability and is a welcome addition to the maintenance treatment of schizophrenia."
01/26/1977 - "Penfluridol: a double blind trial in chronic schizophrenia."
01/01/2006 - "Furthermore, penfluridol is shown to be an adequate treatment option for people with schizophrenia, especially those who do not respond to oral medication on a daily basis and do not adapt well to depot drugs. "
01/01/2006 - "To review the effects of penfluridol for treatment of those with schizophrenia and schizophrenia-like illnesses in comparison to placebo, other antipsychotic medication or no intervention. "
|4.||Psychotic Disorders (Schizoaffective Disorder)
12/18/1971 - "A controlled study was made of penfluridol medication consisting of a single weekly oral dose of 30 mg in 30 patients with acute psychoses of varying type and origin. "
09/01/1976 - "The conclusion is that Penfluridol is a valuable contribution to longterm treatments in psychoses."
09/01/1978 - "[Clinical evaluation of penfluridol--a neuroleptic with prolonged action (oral administration) in the treatment of schizophrenic psychoses]."
|5.||Hypoglycemia (Reactive Hypoglycemia)
04/01/1981 - "Although resting PRL levels were evaluated during initial penfluridol therapy (week 1), hypoglycemia provoked a further substantial PRL increment, not significantly different in magnitude from that induced by hypoglycemia during the drug-free period. "
01/01/1983 - "The consistent sex-related differences in the PRL responses to DA blockade, and to insulin-induced hypoglycemia and in the penfluridol plasma levels in our study support the view that sex-related changes need to be considered not only in the hormonal responses to various pharmacological agents, but also in the assessment of the plasma levels of these drugs."
01/01/1983 - "A preliminary study of sex-related differences in prolactin responses to dopamine blockade and insulin hypoglycemia and in penfluridol plasma levels in schizophrenic patients."
|3.||Clonidine (ST 155)
|4.||Antipsychotic Agents (Antipsychotics)